Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
EndoCeutics Inc.
Age
40–75
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Postmenopausal women (non-hysterectomized)
Women between 40 and 75 years of age.
Willing to participate in the study and sign an informed consent.
Women who have self-identified symptom(s) of vaginal atrophy.
Willing to have endometrial biopsy at screening and end of study (Week 52).
You may not be if
Undiagnosed abnormal genital bleeding.
Hypertension equal to or above 140/90 mm Hg.
The administration of any investigational drug within 30 days of screening visit.
Endometrial hyperplasia, cancer or endometrial histology showing proliferative, secretory or menstrual type characteristics at histologic evaluation of endometrial biopsy performed at screening.
Clareo Health | DHEA Against Vaginal Atrophy - Safety Study of 12 Months
